Searched for
MODERNA SHARES
Dow Jones hits record intraday high before closing lower, S&P 500 and Nasdaq fall - here’s why US stock market started July in redUS stock market today July 1: US markets experienced a mixed trading day as the Dow Jones briefly hit a new intraday record before retreati...
US stocks: US market ends lower as tech stocks weigh on sentimentWall Street ended lower on Friday, with AI chip stocks experiencing a significant downturn while Moderna and other healthcare companies sur...
Women are the first caregivers in this Ebola outbreak and the most at riskEastern Congo faces a rapid Ebola outbreak. Women are primary caregivers, increasing their infection risk. Many lack protective gear, forci...
Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhangModerna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possibl...
Moderna says FDA will consider new flu shot after resolving public disputeThe FDA will now consider Moderna's mRNA flu vaccine application after a dispute over clinical trial design. Moderna agreed to seek full ap...
Moderna shares up 2% as skin cancer vaccine shows sustained benefit in five-year follow-upModerna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of the most dea...
Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkModerna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...
Moderna pulls application for COVID-flu combination shotModerna has withdrawn its application for a combination flu and COVID vaccine, awaiting efficacy data from a late-stage influenza shot tria...
Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayModerna, the COVID-19 vaccine manufacturer, is poised to meet its 2023 sales target as it taps into the private market. Analysts suggest th...
Moderna says updated COVID vaccine is effective against newer variantThe company said its shot generated an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86, which is being tracked by th...
Moderna says booster dose of its COVID-19 vaccine appears protective vs. OmicronModerna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant...
Moderna finds that inventing a COVID-19 vaccine was the easy partModerna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...
Moderna working on booster to combine COVID-19 vaccine with a flu shotFlu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...
India offered 7.5 million doses of Moderna vaccine; no consensus on indemnity clause: SourcesAccording to the sources, the Indian government has put forth certain conditions for finalising the indemnity clause contract and has sent ...
Moderna to join S&P 500, shares jump after hoursModerna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevati...
AstraZeneca has sold its stake in Moderna for more than $1 billion: The TimesAstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...
Moderna's COVID-19 vaccine clears first US FDA hurdleFDA staff said a two-dose regimen of Moderna's vaccine was highly effective in preventing confirmed cases of COVID-19. The comments were ma...
US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...